p53 molecular approach to diagnosis and treatment of esophageal squamous cell carcinoma
Author:
Affiliation:
1. Department of Surgery; Toho University Graduate School of Medicine; Tokyo Japan
Funder
Ministry of Education, Culture, Sports, Science and Technology
Publisher
Wiley
Subject
Gastroenterology,Surgery
Link
http://onlinelibrary.wiley.com/wol1/doi/10.1002/ags3.12179/fullpdf
Reference38 articles.
1. Minimally invasive esophagectomy in the prone position improves postoperative outcomes: role of C-reactive protein as an indicator of surgical invasiveness;Koyanagi;Esophagus,2018
2. Impact of the number and extent of positive lymph nodes in 200 patients with thoracic esophageal squamous cell carcinoma after three-field lymph node dissection;Shimada;World J Surg,2006
3. Improvement in short-term outcomes after esophagectomy with a multidisciplinary perioperative care team;Watanabe;Esophagus,2016
4. Does postoperative morbidity worsen the oncological outcome after radical surgery for gastrointestinal cancers? A systematic review of the literature;Shimada;Ann Gastroenterol,2017
5. The use of neoadjuvant therapy for resectable locally advanced thoracic esophageal squamous cell carcinoma in an analysis of 5016 patients from 305 designated cancer care hospitals in Japan;Tsukada;Int J Clin Oncol,2018
Cited by 35 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Serum NY-ESO-1 antibody as a predictive biomarker for postoperative recurrence of gastric cancer: a multicenter prospective observational study;British Journal of Cancer;2024-02-07
2. Three novel rare TP53 fusion mutations in a patient with multiple primary cancers: a case report;Oncology and Translational Medicine;2024-01-07
3. Serum NY‐ESO‐1 and p53 antibodies as useful tumor markers in gastric cancer;Annals of Gastroenterological Surgery;2023-11-20
4. Comparison between a new assay system, Elecsys® Anti‑p53, and conventional MESACUP™ for the detection of serum anti‑p53 antibodies: A multi‑institutional study;Molecular and Clinical Oncology;2022-06-22
5. A Network Pharmacological Elucidation of the Systematic Treatment Activities and Mechanisms of the Herbal Drug FDY003 Against Esophageal Cancer;Natural Product Communications;2022-06
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3